Results 51 to 60 of about 1,543,210 (202)

Prevalence of Acute Kidney Injury in Patients with Liver Cirrhosis

open access: yesJournal of Nepal Medical Association, 2020
Introduction: Acute kidney injury is a common and life-threatening event in patients with liver cirrhosis occurring in approximately 20-50% of hospitalized patients of liver cirrhosis. Pre-renal acute kidney injury, the hepatorenal syndrome type of acute
Pukar Thapa   +9 more
doaj   +1 more source

Determinants of Early Renal Function Recovery After TIPS in Patients With Portal Hypertension

open access: yesThe Kaohsiung Journal of Medical Sciences, EarlyView.
ABSTRACT Renal dysfunction frequently occurs in patients with portal hypertension and is linked to unfavorable clinical outcomes. Transjugular intrahepatic portosystemic shunt (TIPS) has the potential to enhance renal perfusion through portal decompression; however, factors predicting early improvement in renal function remain insufficiently defined ...
Meng Jia   +6 more
wiley   +1 more source

Hepatorenal syndrome in cirrhotic patients in Madagascar: epidemiology, clinical profile and in-hospital outcomes

open access: yesAfrican Journal of Nephrology, 2021
Background: Hepatorenal syndrome (HRS) is a frequent and serious complication in decompensated cirrhosis. The objective of this study was to describe the epidemiology, clinical profiles and outcomes of hepatorenal syndrome (HRS).
Chantelli Iamblaudiot Razafindrazoto   +2 more
doaj   +1 more source

Adjusted hazard ratios of hepatorenal syndrome group for the 30-day, 30 to 90-day, 90-day to 1-year, and 1 to 3-year mortality of cirrhotic patients with acute renal failure, compared to non-hepatorenal syndrome group.

open access: yes, 2016
Adjusted hazard ratios of hepatorenal syndrome group for the 30-day, 30 to 90-day, 90-day to 1-year, and 1 to 3-year mortality of cirrhotic patients with acute renal failure, compared to non-hepatorenal syndrome group.
Chorng-Jang Lay (3122004)   +4 more
core   +1 more source

COMPARISON OF EFFICACY ON NORADRENALINE AND TERLIPRESSIN IN HEPATORENAL SYNDROME IN THE PATIENTS OF DECOMPENSATED CIRRHOSIS – A RANDOMIZED CONTROLLED STUDY

open access: yesPakistan Armed Forces Medical Journal, 2019
Objective: To compare the efficacy of noradrenaline and terlipressin in hepatorenal syndrome. Study Design: Randomized controlled trial. Place and Duration of Study: Combined Military Hospital Lahore, from May 2018 to Jan 2019.
Muhammad Siddique   +2 more
doaj   +4 more sources

Features of the course of hepatorenal syndrome in decompensated portal hypertension (case report)

open access: yesGastroenterologìa
Hepatorenal syndrome is a critical and potentially life-threatening complication in patients with advanced liver cirrhosis, characterized by the development of renal dysfunction in the absence of underlying structural kidney disease.
M.I. Tutchenko   +4 more
doaj   +1 more source

Predictors of hepatorenal syndrome in alcoholic liver cirrhosis

open access: yesBiomedical Papers, 2015
Background: Alcoholic liver disease is a major cause of liver cirrhosis and the hepatorenal syndrome is a serious complication. Risk factors for hepatorenal syndrome (HRS) in alcoholic liver cirrhosis are not entirely explored.
Martin Janicko   +3 more
doaj   +1 more source

Diagnosis of Portal Hypertension: Advancing Towards Non‐Invasive Solutions

open access: yesPortal Hypertension &Cirrhosis, EarlyView.
This review systematically summarizes a full spectrum of non‐invasive diagnostic approaches for portal hypertension (PH), including imaging modalities, elastography, serum biomarkers, composite scoring systems and endoscopic ultrasound‐guided portal pressure gradient (EUS‐PPG), and analyzes their performance across different liver disease etiologies ...
Lijia Yin, Huikuan Chu, Ling Yang
wiley   +1 more source

Do old urinary biomarkers have a place in the new definition of hepatorenal syndrome in the Egyptian cirrhotic patients? A single-center experience

open access: yesEgyptian Liver Journal, 2022
Background Hepatorenal syndrome is still a diagnosis of exclusion despite new classification. Aims To validate the accuracy of urinary neutrophil gelatinase-associated lipocalin, interleukin-18, and kidney injury molecule-1 in the new diagnostic criteria
Mona Abd El-Rahman Abu El-Makarem   +4 more
doaj   +1 more source

Dietary Flavonoid Hyperoside Ameliorates High‐Fat Diet‐Induced Type 2 Diabetes Mellitus by Enhancing Brown Adipose Tissue Thermogenesis, White Adipose Tissue Browning, and Gut Microbiota Remodeling

open access: yesPhytotherapy Research, EarlyView.
Hyperoside ameliorates metabolic dysfunction in high‐fat diet‐induced type 2 diabetic mice, accompanied by enhanced brown adipose tissue thermogenic activity, inguinal white adipose tissue browning‐related changes, reduced M1 macrophage polarization, and gut microbiota remodeling.
WeiFeng Cai   +7 more
wiley   +1 more source

Home - About - Disclaimer - Privacy